T790M is a secondary mutation in the EGFR kinase domain (exon 20) that is identified to be the primary resistance mechanism for EGFR tyrosine kinase inhibitor, which is detected in approximately 60% of EGFR-TKI resistance in NSCLC cases45,46. This evidence concerns the gene EGFR and non-small cell lung carcinoma.